|
已选(0)清除
条数/页： 排序方式： |
| Pan-cancer analyses demonstrate that ANKRD6 is associated with a poor prognosis and correlates with M2 macrophage infiltration in colon cancer 期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2021, 卷号: 33
作者: Bai, Rui; Wu, Dehao; Shi, Zhong; Hu, Wangxiong; Li, Juan; Chen, Yuanyuan; Ge, Weiting; Yuan, Ying; Zheng, Shu
  收藏 | 浏览/下载：48/0 | 提交时间：2021/04/26
ANKRD6 colon cancer pan-cancer prognosis tumor-infiltrating |
| Clinicopathological features and surgical outcomes of four rare subtypes of primary liver carcinoma 期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2018, 卷号: 30
-
收藏 | 浏览/下载：29/0 | 提交时间：2020/10/26
SARCOMATOID HEPATOCELLULAR-CARCINOMA CLEAR-CELL CARCINOMA OF-THE-LITERATURE CHOLANGIOCELLULAR CARCINOMA GIANT-CELLS CHOLANGIOCARCINOMA DIAGNOSIS SURGERY Clear cell carcinoma combined hepatocellular-cholangiocarcinoma giant cell carcinoma sarcomatoid carcinoma hepatocellular carcinoma |
| Exploratory clinical study of chidamide, an oral subtype-selective histone deacetylase inhibitor, in combination with exemestane in hormone receptor-positive advanced breast cancer 期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2018, 卷号: 30
-
收藏 | 浏览/下载：34/0 | 提交时间：2020/10/26
PHASE-I POSTMENOPAUSAL WOMEN HDAC INHIBITOR MULTICENTER ENTINOSTAT TAMOXIFEN CS055/HBI-8000 RESISTANCE LETROZOLE TRIAL Advanced breast cancer hormone receptor-positive chidamide exemestane |
| Management of extramedullary plasmacytoma: Role of radiotherapy and prognostic factor analysis in 55 patients 期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2017, 卷号: 29
-
收藏 | 浏览/下载：24/0 | 提交时间：2020/10/26
SOLITARY PLASMACYTOMA RADIATION-THERAPY CLINICAL-FEATURES ONCOLOGY-GROUP SOFT-TISSUE NECK HEAD BONE MULTICENTER GUIDELINES Extramedullary plasmacytoma prognostic factors radiotherapy multiple myeloma |
| Clinical characteristics and response to tyrosine kinase inhibitors of patients with non-small cell lung cancer harboring uncommon epidermal growth factor receptor mutations 期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2017, 卷号: 29
-
收藏 | 浏览/下载：33/0 | 提交时间：2020/10/26
EGFR MUTATIONS GEFITINIB TREATMENT 1ST-LINE TREATMENT OPEN-LABEL RARE MULTICENTER ERLOTINIB GENE CHEMOTHERAPY EFFICACY Non-small cell lung cancer EGFR uncommon mutation target therapy |
| Expression of VEGFR2 and NRP-1 in non-small cell lung cancer and their clinical significance 期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2014, 卷号: 26
-
收藏 | 浏览/下载：35/0 | 提交时间：2020/10/26
ENDOTHELIAL GROWTH-FACTOR TUMOR-CELLS CARCINOMA NEUROPILIN-1 RECEPTORS VEGF(165) Non-small cell lung cancer (NSCLC) vascular endothelial growth factor receptor 2 (VEGFR2) neuropilin-1 (NRP-1) fluorescence in situ hybridization (FISH) |
| Autophagy inhibition enhances apigenin-induced apoptosis in human breast cancer cells 期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2013, 卷号: 25
-
收藏 | 浏览/下载：39/0 | 提交时间：2020/10/26
CYCLE ARREST MOLECULAR-MECHANISMS ARSENIC TRIOXIDE SELF-DIGESTION NUDE MICE EXPRESSION INDUCTION DEATH CHEMOPREVENTION CHEMOTHERAPY Apoptosis autophagy apigenin breast cancer 3-methyladenine |
| Recombinant adenovirus-p53 (Gendicine) sensitizes a pancreatic carcinoma cell line to radiation 期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2013, 卷号: 25
-
收藏 | 浏览/下载：23/0 | 提交时间：2020/10/26
P53 GENE-TRANSFER ADENOCARCINOMA CELLS TUMOR-REGRESSION CANCER RADIOTHERAPY THERAPY DELIVERY THERAPEUTICS GEMCITABINE COMBINATION Pancreatic carcinoma recombinant adenovirus-p53 (rAd-p53) transfection radiosensitization |
| Recurrence risk model for esophageal cancer after radical surgery 期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2013, 卷号: 25
-
收藏 | 浏览/下载：35/0 | 提交时间：2020/10/26
SQUAMOUS-CELL CARCINOMA METASTATIC LYMPH-NODES TOTAL NUMBER SURVIVAL JUNCTION DISEASE PATTERN LYMPHADENECTOMY RESECTION UNION Esophageal cancer radical surgery recurrence model |
| Recursive Partitioning Analysis Classification and Graded Prognostic Assessment for Non-Small Cell Lung Cancer Patients with Brain Metastasis: A Retrospective Cohort Study 期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2011, 卷号: 23
-
收藏 | 浏览/下载：22/0 | 提交时间：2020/10/26
CLINICAL-PRACTICE GUIDELINE SURGICAL-TREATMENT RADIATION-THERAPY ANALYSIS RPA STEREOTACTIC RADIOSURGERY MANAGEMENT CHEMOTHERAPY RADIOTHERAPY ERLOTINIB SURVIVAL Non-small cell lung cancer (NSCLC) Brain metastasis Prognosis Recursive partitioning analysis Graded prognostic assessment |
